Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
53 /100
HIGH RISK
Score updated Oct 13, 2026

GLMD — Galmed Pharmaceuticals Ltd. Dilution Risk Tracker

Track GLMD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GLMD — Get alerts when the score changes →

As of October 13, 2026, Galmed Pharmaceuticals Ltd. (GLMD) has a DilutionWatch DilutionScore of 53/100, rated HIGH dilution risk. Galmed Pharmaceuticals Ltd. has a market capitalization of $30.47M, 6.58M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include 173.3K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
25
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.62 below $1 exchange minimum
🔔 Track GLMD — Get forecast alerts →

Market Data

Market Cap$30.47M
Shares Outstanding6.58M
Float6.37M
Cash$9.88M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore53/100DilutionWatch score record
Shares Outstanding6.58MVerified float table or market cache
Public Float6.37MVerified float table or market cache
Market Cap$30.47MMarket data cache
Cash Runway18.8 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants173.3KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 3 4, EFFECT 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

10 institutional holders · 221.6K shares
#1 Two Sigma Investments, LP 112.1K shares
#2 Citadel Advisors Llc 38.2K shares
#3 Two Sigma Advisers, LP 31.5K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest19.6K
Days to Cover1.0
% of Float0.3%
FINRA data as of Aug 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2016-03-22
EFFECT EFFECT 2026-04-01
3 FORM3 2026-03-18
3 FORM3 2026-03-18
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual GLMD Dilution Snapshot

Galmed Pharmaceuticals Ltd. (GLMD) has a DilutionScore of 53/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

GLMD's DilutionScore is currently 53/100 (High risk), with 6 score changes tracked over 89 days. The score deteriorated from 56/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202653/100HIGH16 days
Sep 14 – Sep 27, 202656/100HIGH14 days
Sep 03 – Sep 13, 202657/100HIGH11 days
Aug 24 – Sep 02, 202645/100MEDIUM10 days
Aug 22 – Aug 23, 202657/100HIGH2 days
Jul 17 – Aug 21, 202656/100HIGH35 days
Jul 16, 202657/100HIGH1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track GLMD Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment GLMD files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking GLMD — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GLMD
GLMD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.